Reporter Sept 21 2012
Sep. 21, 2012—Vanderbilt University and Bristol-Myers Squibb have signed a collaboration agreement for the discovery, development and commercialization of novel therapies acting on the mGluR4 glutamate receptor, known as positive allosteric modulators, or PAMs, for the treatment of Parkinson’s disease.
Sep. 20, 2012—Hassane Mchaourab, Ph.D., professor of Molecular Physiology & Biophysics, Physics and Chemistry, has been named the new director of the Ph.D.-granting Chemical and Physical Biology (CPB) program at Vanderbilt University.
Sep. 20, 2012—Adult cancer patients and survivors are invited to participate in Vanderbilt-Ingram Cancer Center’s new Thrivership Program, which is designed to restore wellness through physical activity, enhanced nutrition, body awareness and emotional well-being.
Sep. 20, 2012—William Schaffner, M.D., professor and chair of Preventive Medicine, is the 2012 recipient of the American College of Epidemiology’s Abraham Lilienfeld Award, in recognition of his contributions and leadership in the discipline of epidemiology.
Sep. 20, 2012—Psychiatrist and fear researcher Kerry Ressler, M.D., Ph.D., will deliver the next Flexner Discovery Lecture on Thursday, Sept. 27.
Sep. 20, 2012—LaManda Watson, left, receives a Team Vanderbilt T-shirt from Elizabeth Wilson for participating in the Fall Cancer Walks signup event held recently. Vanderbilt-Ingram Cancer Center is sponsoring at least eight cancer walks this fall. For more information and to register online, visit www.viccfallwalks.org.
Sep. 20, 2012—Three Vanderbilt Transplant Center programs were recently recognized for having high-performing outcomes by the Donation and Transplantation Community of Practice of the Health Resources and Services Administration.